For oral use.
The capsules must be taken with a sufficient quantity of water (at least 100 ml). They must not be chewed because the coating is designed for a controlled release mechanism (see Pharmacology: Pharmacokinetics under Actions).
Adults over the age of 18 years: Twice daily 1 capsule of 200 mg, one in the morning and one in the evening.
There are no safety risks for a duration of use up to 1 year. However, when the desired effect has been achieved after a few weeks, the dose may be reduced gradually.
If one or more doses have not been taken, the patient must continue with the next dose as prescribed; the missed dose should not be taken on top of the usual dose.
Pediatric population: Duspatalin Retard should not be used in children and adolescents below the age of 18 years because the safety and efficacy have not been established in this group.
Elderly patients and patients with kidney and/or liver disorders: No dose studies have been performed in elderly patients and patients with kidney and/or liver disorders.